Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2002
11/19/2002US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002US6482612 Adipocyte-specific protein homologs
11/19/2002US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002US6482517 Coated particles, methods of making and using
11/19/2002US6482409 Treatment for inflammatory bowel disease with a vcam-1/1gG fusion protein
11/19/2002CA2312667C Novel cytokine
11/19/2002CA2272990C Heptapeptide oxytocin analogues
11/19/2002CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/19/2002CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/19/2002CA1341399C Intercellular adhesion molecules and their binding ligands
11/14/2002WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002WO2002090530A2 Kinases and phosphatases
11/14/2002WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002WO2002090375A2 Liver x receptor agonists
11/14/2002WO2002090353A1 Sulfonamides
11/14/2002WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002WO2002090337A1 Sulfonamides
11/14/2002WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002089819A1 Glycoconjugates and uses thereof
11/14/2002WO2002089796A2 Methods for selective immunomodulation using pimecrolimus
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002089787A1 Potentiation of therapeutic effects of fatty acids
11/14/2002WO2002089785A1 Sulfonamides
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002089770A2 Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine
11/14/2002WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002WO2002089743A2 Use of compositions for treating rosacea
11/14/2002WO2002089740A2 Sulfonamides
11/14/2002WO2002089730A2 Compounds and methods for the modulation of cd154
11/14/2002WO2002076990A8 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
11/14/2002WO2002076476A3 Prodrugs of anticancer agents employing substituted aromatic acids
11/14/2002WO2002074326A3 Urocortin-iii and uses thereof
11/14/2002WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002WO2002066028A3 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/14/2002WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002WO2002049634A3 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
11/14/2002WO2002045688A3 Composition for treatment of inflammatory disorders
11/14/2002WO2002030385A3 Anti-inflammatory active ingredients
11/14/2002WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002WO2002018404A3 Nucleoside derivatives for the treatment of hepatitis c
11/14/2002WO2002011530A9 Transgenic animal
11/14/2002WO2001035106A3 Methods for identifying and using amyloid-inhibitory compounds
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002US20020169215 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
11/14/2002US20020169209 Potentiation of therapeutic effects of fatty acids
11/14/2002US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof
11/14/2002US20020169171 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
11/14/2002US20020169166 Benzimidazoles that are useful in treating sexual dysfunction
11/14/2002US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002US20020169163 1,2,3,4-tetrahydro-pyrazino(1,2-a)indole derivatives useful in treating obesity, central nerveous system diosrders, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, type II diabetes, obesity and sleep apnoea
11/14/2002US20020169160 Sulfonamide matrix metalloproteinase inhibitors
11/14/2002US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002US20020169156 Azacyclooctane and heptane derivatives, their preparation and use in therapy
11/14/2002US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002US20020169150 Hormone replacement therapy
11/14/2002US20020169144 Angiogenesis inhibition
11/14/2002US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002US20020169114 Formulation of boronic acid compounds
11/14/2002US20020169105 Use of active enamel substances as wound healing, anti-bacterial and/or anti-inflammatory agents
11/14/2002US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002US20020168712 Molecules designated LDCAM
11/14/2002US20020168690 Peptide for use in the treatment of arthritis
11/14/2002US20020168436 Decursinol or derivative thereof as analgesic agent
11/14/2002US20020168434 Cyclooxygenase inhibitor; anticancer agents, Alzheimer's disease, central nervous system disorders
11/14/2002US20020168411 Spill resistant pharmaceutical system
11/14/2002US20020168397 Antiallergens, antiinflammatory agents; oral administering
11/14/2002US20020168363 Integrin/adhesion antagonists
11/14/2002US20020168360 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphanubeta3 antagonists in combination with other prophylactic or therapeutic agents
11/14/2002US20020168358 Modulating the binding of the particular chemokines SLC (secondary lymphoid chemokine), and MIP-3b (macrophage inflammatory protein-3b), to immune system T-cells and dendritic cells to treat adverse inflammatory responses etc
11/14/2002DE10213304A1 Topical pharmaceutical composition having carrier system forming lamellar double membrane structure with water, providing good skin barrier permeation and high bioavailability without side-effects
11/14/2002DE10122894A1 New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
11/14/2002CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002CA2446365A1 Sulfonamides
11/14/2002CA2446363A1 Potentiation of therapeutic effects of fatty acids
11/14/2002CA2446120A1 Novel arylheteroalkylamine derivatives
11/14/2002CA2446051A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002CA2442969A1 Methods for selective immunomodulation using pimecrolimus
11/14/2002CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002CA2435142A1 Kinases and phosphatases
11/14/2002CA2385809A1 Alkylamide compounds
1 ... 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 ... 1272